DaVita Inc. (NYSE:DVA) Shares Acquired by iA Global Asset Management Inc.

iA Global Asset Management Inc. lifted its position in DaVita Inc. (NYSE:DVA) by 60.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,655 shares of the company’s stock after purchasing an additional 2,497 shares during the period. iA Global Asset Management Inc.’s holdings in DaVita were worth $1,091,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Harvard Management Co. Inc. acquired a new position in shares of DaVita in the second quarter worth about $55,115,000. KBC Group NV raised its holdings in DaVita by 27.3% in the 3rd quarter. KBC Group NV now owns 313,519 shares of the company’s stock worth $51,395,000 after purchasing an additional 67,250 shares during the period. BNP Paribas Financial Markets boosted its position in DaVita by 23.9% during the third quarter. BNP Paribas Financial Markets now owns 292,039 shares of the company’s stock worth $47,874,000 after purchasing an additional 56,389 shares in the last quarter. Andra AP fonden grew its holdings in DaVita by 9.0% in the second quarter. Andra AP fonden now owns 192,300 shares of the company’s stock valued at $26,647,000 after purchasing an additional 15,800 shares during the period. Finally, abrdn plc increased its position in shares of DaVita by 1.2% in the third quarter. abrdn plc now owns 189,065 shares of the company’s stock valued at $30,719,000 after buying an additional 2,180 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at DaVita

In related news, CEO Javier Rodriguez sold 9,881 shares of DaVita stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $162.85, for a total transaction of $1,609,120.85. Following the transaction, the chief executive officer now owns 887,835 shares in the company, valued at approximately $144,583,929.75. This trade represents a 1.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

DVA has been the topic of a number of research analyst reports. Barclays lifted their price target on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial lifted their target price on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, DaVita presently has a consensus rating of “Hold” and an average target price of $161.80.

DaVita Stock Down 1.4 %

NYSE DVA opened at $158.05 on Tuesday. DaVita Inc. has a one year low of $103.40 and a one year high of $169.51. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The business has a fifty day moving average price of $158.46 and a 200 day moving average price of $150.52. The company has a market cap of $12.96 billion, a P/E ratio of 17.05, a P/E/G ratio of 0.90 and a beta of 0.90.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business had revenue of $3.26 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same period in the prior year, the business posted $2.85 earnings per share. The business’s quarterly revenue was up 4.6% on a year-over-year basis. Research analysts anticipate that DaVita Inc. will post 9.71 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.